Access to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemic

dc.contributor.author	Pan American Health Organization
dc.date.accessioned	2020-09-21T19:34:34Z
dc.date.available	2020-09-21T19:34:34Z
dc.date.issued	2020-07-13
dc.identifier.uri	https://hdl.handle.net/20.500.12663/2199
dc.description.abstract	Appropriate and adequate management of people with noncommunicable diseases (NCDs) includes access to essential NCD medicines. Disrupted access to chronic medication for hypertension, diabetes, heart disease, mental health disorders, cancer, and asthma could result in severe disease exacerbation and potentially death.
dc.language	English
dc.subject	Infecctious Diseases
dc.subject	COVID-19
dc.subject	Coronavirus
dc.title	Access to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemic
eihealth.country	Regional, Americas (PAHO/OPS)
eihealth.category	Infection prevention and control, including health care workers protection
eihealth.type	WHO/PAHO Guidance
eihealth.maincategory	Slow Spread / Reducir la Dispersión

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.